Preferred Label : ezogabine;

MeSH note : structure in first source;

CISMeF synonym : D 20443; D 23129; ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride; potiga;

MeSH synonym : N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester; retigabine;

MeSH hyponym : D-20443; D-23129;

MeSH Related Number : 150812-12-7 (ezogabine);

Registry Number MeSH : 150812-12-7;

Is substance : O;

UNII : 12G01I6BBU;

InChIKey : PCOBBVZJEWWZFR-UHFFFAOYSA-N;

Details


Main resources

You can consult :


http://www.has-sante.fr/portail/jcms/c_1739172/fr/trobalt-retigabine-antiepileptique
http://www.has-sante.fr/portail/jcms/c_1121545/trobalt-retigabine-antiepileptique-synthese-d-avis
2014
false
France
French
guidelines for drug use
evaluation of the transparency committee
carbamates
carbamates
phenylenediamines
phenylenediamines
retigabine
administration, oral
anticonvulsants
epilepsies, partial
ezogabine
insurance, health, reimbursement
treatment outcome
potassium channels
drug therapy, combination
adult
ezogabine
anticonvulsants
ezogabine
ezogabine

---
http://www.has-sante.fr/portail/jcms/c_1078992/trobalt
http://www.has-sante.fr/portail/jcms/c_1337586/trobalt-ct-10681-version-anglaise
http://www.has-sante.fr/portail/jcms/c_1739172/fr/trobalt
2014
false
France
French
English
guidelines for drug use
evaluation of the transparency committee
ezogabine
administration, oral
insurance, health, reimbursement
carbamates
phenylenediamines
anticonvulsants
retigabine
adult
treatment outcome
epilepsies, partial
ezogabine
anticonvulsants
carbamates
phenylenediamines
ezogabine
ezogabine

---
Summary Basis of Decision (SBD) for Potiga
Ezogabine , 50 mg, 100 mg, 200 mg, 300 mg, and 400 mg , tablets, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00264
2013
false
Canada
English
French
drug information
Product containing precisely retigabine 50 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely retigabine 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely retigabine 200 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely retigabine 300 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely retigabine 400 milligram/1 each conventional release oral tablet (clinical drug)
ezogabine
ezogabine
administration, oral
anticonvulsants
anticonvulsants
drug approval
canada
epilepsies, partial
membrane transport modulators
membrane transport modulators
adult
treatment outcome
randomized controlled trials as topic
drug therapy, combination
carbamates
carbamates
phenylenediamines
phenylenediamines

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65572885
2012
France
summary of product characteristics
package leaflet
tablets
ezogabine
ezogabine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67559573
2012
France
summary of product characteristics
package leaflet
ezogabine
ezogabine
tablets

---
https://www.ema.europa.eu/medicines/human/EPAR/Trobalt
2012
United Kingdom
English
French
syndication feed
ezogabine
ezogabine
carbamates
carbamates
phenylenediamines
phenylenediamines
anticonvulsants
anticonvulsants
retigabine
drug approval
treatment outcome
administration, oral
adult
epilepsies, partial
drug therapy, combination
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
kcnq2 potassium channel
kcnq3 potassium channel
ezogabine
ezogabine
summary of product characteristics
package leaflet
drug evaluation

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69285352
2012
France
summary of product characteristics
package leaflet
ezogabine
ezogabine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65039855
2012
France
summary of product characteristics
package leaflet
ezogabine
tablets
ezogabine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66263176
2012
France
summary of product characteristics
package leaflet
tablets
ezogabine
ezogabine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68787590
2012
France
summary of product characteristics
package leaflet
tablets
ezogabine
ezogabine

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.